Actavis Group hf. · Hafnarfirdi Iceland
Company Description
View Actavis Group hf. Locations On A US Map
This link will open in a new window
This link will open in a new window Actavis is Icelandic for generic. Iceland-based Actavis Group is one of the world's largest generic pharmaceuticals producers. The company has about 350 drugs in its development pipeline, and nearly 1,000 products on the market across a variety of therapeutic classes (among them cardiovascular, gastrointestinal, and oncology). It also manufactures generic hospital products, including antibiotics, anesthetics, and painkillers. Actavis makes drugs in pill, injectable, suppository, and other forms. Subsidiary Medis distributes its drugs worldwide. Actavis, which was founded in 1956, is controlled by chairman Thor Bjorgolfsson through his investment vehicle Novator. At the company's helm is CEO Sigurdur Oli Olafsson.
To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Actavis Group hf. Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Actavis Group hf. Financials
| Company Type | Private Headquarters |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $0.0 |
| 2008 Employees | 10,000 |
Actavis Group hf. Executives
43 executives listed for Actavis Group hf.'s Hafnarfirdi Iceland location.
| Title | Name & Bio | Contact |
| Chairman | Thor Bjorgolfsson | |
| CEO and Director | Sigurdur Olafsson | |
| Deputy CEO | Gudbjorg Eggertsdottir |
Competition
Competitive Landscape for Actavis Group hf.
Demand is driven largely by industry and government spending on R&D to improve the efficiency of operations and develop new products and services. The profitability of individual companies depends on technical expertise and the ability to accurately predict project costs. Large labs have advantages in providing a larger breadth of service through multiple locations; some have strategic partnerships with major corporations. Small labs compete effectively by specializing in particular types of service. The industry is labor-intensive: average revenue per worker is less than $100,000. Testing labs compete with internal labs of major corporations and government entities. To read the full description, subscribe now.Top Actavis Group hf. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!